Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2011
07/20/2011CN101519372B Benzo [e] isoindazole-1,3 diketone compound used as GSK inhibiting agent and preparation method thereof
07/20/2011CN101287734B 2-amino-7,8-dihydro-6h-pyrido[4,3-d]pyrimidin-5-ones
07/20/2011CN101255161B Method for synthesizing 3,9-diaza-2,4-dioxo-spiro[5.5] undecane template compounds
07/19/2011US7982213 Phenanthroline compound and organic light emitting device using same
07/19/2011US7982042 Thiozanthene derivatives as delta-opioid modulators
07/19/2011US7982041 Camptothecin analogs and methods of preparation thereof
07/19/2011US7982039 N-type semiconductors and related devices
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981975 Heterodiamondoids
07/19/2011US7981904 Acetyl CoA carboxylase inhibitors
07/19/2011US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/19/2011US7981881 Fused heterocyclic compounds and use thereof
07/19/2011US7981525 Naphthalene compound and organic light-emitting device using the compound
07/19/2011CA2526663C Indole derivatives with apoptosis-inducing effect
07/19/2011CA2487494C Spiroindolinepiperidine derivatives
07/19/2011CA2441996C Non-nucleoside reverse transcriptase inhibitors
07/19/2011CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids
07/14/2011WO2011084726A1 BIS [4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM] 4-[(3-CARBOXYLATO-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS
07/14/2011WO2011084725A1 4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM 1-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS
07/14/2011WO2011084439A1 Tetrahydrocarboline derivatives as eg5 inhibitors
07/14/2011WO2011084434A2 Aza-ring fused indole and indoline derivatives
07/14/2011WO2011084433A2 Aza-bridged ring-fused indoles and indolines
07/14/2011WO2011083823A1 Prophylactic or therapeutic agent for schizophrenia
07/14/2011WO2011083316A1 Benzazepine derivatives for the treatment of central nervous system disorders
07/14/2011WO2011083278A1 Novel benzoic pyrrolopyridine derivatives
07/14/2011WO2011083275A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
07/14/2011WO2011030224A3 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
07/14/2011US20110173726 Pyrazole Compounds for Controlling Invertebrate Pests
07/14/2011US20110172427 Process for preparing certain cinnamide compounds
07/14/2011US20110172420 Sulfonamide derivatives of polycyclic dyes used for analytical applications
07/14/2011US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group
07/14/2011US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
07/14/2011US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
07/14/2011US20110172256 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
07/14/2011US20110172255 Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists
07/14/2011US20110172254 Folate receptor binding conjugates of antifolates
07/14/2011US20110172252 Triazolo[4,5-d]pyramidine derivatives and their use as purine receptor antagonists
07/14/2011US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease
07/14/2011US20110172227 Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective m1 agonists and methods of making and using same
07/14/2011US20110172224 Novel heterocycles
07/14/2011US20110172218 Cgrp antagonists
07/14/2011US20110172212 Amine-based compound and use thereof
07/14/2011US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders
07/14/2011US20110172205 Monocyclic amide cgrp receptor antagonists
07/14/2011US20110172203 Substituted Imidazopyridinyl-Aminopyridine Compounds
07/14/2011US20110171739 Ligands for aggregated tau molecules
07/14/2011US20110171678 Modified carbocyanine dyes and their conjugates
07/14/2011CA2804034A1 Prodrugs of heteraromatic compounds
07/14/2011CA2786534A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
07/14/2011CA2785876A1 Novel benzoic pyrrolopyridine derivatives
07/13/2011EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
07/13/2011EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
07/13/2011EP2343297A1 Triazolopyridines
07/13/2011EP2343296A1 A process for the purification of paliperidone
07/13/2011EP2343295A1 Triazolopyridine derivates
07/13/2011EP2343294A1 Substituted triazolopyridines
07/13/2011EP2343291A1 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
07/13/2011EP2342204A1 Novel polymorph of moxifloxacin hydrochloride
07/13/2011EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
07/13/2011EP2342202A1 Azaindole derivative
07/13/2011EP2342201A1 Indole derivatives as crth2 receptor antagonists
07/13/2011EP2342190A1 Bicyclic kinase inhibitors
07/13/2011EP2341777A1 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
07/13/2011EP1852434B1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
07/13/2011CN1938315B Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
07/13/2011CN1871233B Novel chelating agents and chelates and their use
07/13/2011CN1353609B Amide substituted imidazoquinolines
07/13/2011CN102124008A Novel derivatives of pyrroloindole inhibitors of Hsp90, compositions containing same, and use thereof
07/13/2011CN102124007A Azacarboline derivatives, preparation method thereof and therapeutic use of same
07/13/2011CN102124006A Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
07/13/2011CN102124005A Cmet inhibitors
07/13/2011CN102123990A Heterocyclic compound and use thereof
07/13/2011CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
07/13/2011CN101531659B Calycanthine reference substance preparation method
07/12/2011US7977484 Pradofloxacin trihydrate; thermodynamically stable and is not converted to other crystal forms even during prolonged storage; non-hygroscopic
07/12/2011US7977378 Compositions and methods for enhancing weight-loss by cyclical administration of compounds
07/12/2011US7977374 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
07/12/2011US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/12/2011US7977351 Heteroaryl dihydroindolones as kinase inhibitors
07/12/2011US7977338 Phenylacetamides being FLT3 inhibitors
07/12/2011US7977331 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
07/12/2011CA2679198C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
07/12/2011CA2663401C Pyrido (2, 3-d) pyrimidinone compounds and their use as pi3 inhibitors
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2498275C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
07/12/2011CA2470721C Superoxide dismutase mimics for the treatment of ocular disorders and diseases
07/12/2011CA2461202C Lactam-containing compounds and derivatives thereof as factor xa inhibitors
07/12/2011CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
07/12/2011CA2351712C Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
07/07/2011WO2011082266A2 Substituted heterocyclic compounds
07/07/2011WO2011082234A1 Thionated aromatic bisimides as organic semiconductors and devices incorporating them
07/07/2011WO2011082010A1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
07/07/2011WO2011081174A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
07/07/2011WO2011081173A1 Tetracyclic compound
07/07/2011WO2011081065A1 Compound and organic electroluminescent element using said compound
07/07/2011WO2011080758A2 Improved process for the preparation of substituted quinoxalines
07/07/2011WO2011080755A1 Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
07/07/2011WO2011080444A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011WO2011079804A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
07/07/2011WO2011033163A3 Sod-imitating metal complexes